dopamine inhibited adenylate cyclase activity by 28.8 +/- 5.6 % in five bromocriptine-responsive tumors and by 16.5 +/- 4.3 % in adenomas from eight resistant patients .
C0006230
bromocriptine
C0001430
adenomas